BCTXZ Stock Summary and Trading Ideas (Briacell Therapeutics Corp. - Warrant | NASDAQ:BCTXZ)

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Briacell Therapeutics Corp. - Warrant trades on the NASDAQ stock market under the symbol BCTXZ.

As of July 14, 2026, BCTXZ stock price was flat at $0.10 with 397,610 million shares trading.

BCTXZ has a beta of 3.86, meaning it tends to be more sensitive to market movements. BCTXZ has a correlation of 0.09 to the broad based SPY ETF.

BCTXZ has a market cap of $0.00. This is considered a Sub-Micro Cap stock.

BCTXZ has underperformed the market in the last year with a return of -80.0%, while the SPY ETF gained +21.8%. In the last 3 month period, BCTXZ fell short of the market, returning -29.4%, while SPY returned +9.9%. However, in the most recent 2 weeks BCTXZ has outperformed the stock market by returning +25.0%, while SPY returned +1.5%.

BCTXZ support price is $.09 and resistance is $.11 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BCTXZ shares will trade within this expected range on the day.